Global Endowment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,980
Closed -$495K 113
2019
Q3
$495K Sell
4,980
-610
-11% -$58K 0.04% 59
2019
Q2
$517K Hold
5,590
0.05% 95
2019
Q1
$527K Hold
5,590
0.07% 164
2018
Q4
$358K Buy
+5,590
New +$413K 0.08% 115

Other funds holding CELG

Global Endowment Management's CELG Position: Q4 2019 in Review

Global Endowment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,980 shares — an estimated $495K sold.

Global Endowment Management first reported a position in CELG in Q4 2018 and held it in 4 quarters. The position peaked at $527K in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Global Endowment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Global Endowment Management sold 4,980 Celgene Corp shares in Q4 2019, an estimated $495K.
  • Global Endowment Management first reported a position in Celgene Corp in Q4 2018 and held it in 4 quarters.
  • Global Endowment Management's Celgene Corp position peaked at $527K in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Global Endowment Management's 13F filing for Q4 2019, filed 12 Feb 2020.